MDXG Q4 2025 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$118M+27.1% YoY

Gross Profit

$99M83.9% margin

Operating Income

$21M17.8% margin

Net Income

$15M12.9% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+3.8%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$25M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$343M

Total Liabilities

$86M

Stockholders' Equity

$257M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$118M	$93M	+27.1%
Gross Profit	$99M	$76M	+30.3%
Operating Income	$21M	$11M	+90.7%
Net Income	$15M	$7M	+104.2%

Revenue Segments

Surgical

$39M100%